Get started
Author

Llew Keltner

Observed names: L. Keltner, LLEW KELTNER
OpenAlex ID: A5069041286
New Technology for Deep Light Distribution in Tissue for Phototherapy
2002 · James Chen, Llew Keltner, et al. · The Cancer Journal · 175
Talaporfin sodium
2009 · S Wang, Elizabeth Bromley, et al. · Expert Opinion on Pharmacotherapy · 71
Characterization of cutaneous photosensitivity in healthy volunteers receiving talaporfin sodium
2011 · Elizabeth Bromley, Brittany Briggs, et al. · Photodermatology Photoimmunology & Photomedicine · 18
Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer Agents
2015 · George Dranitsaris, Roger B. Cohen, et al. · Journal of Immunotherapy · 10
A phase I/II safety and efficacy study of intratumoral light-activated drug therapy using talaporfin sodium in patients with inoperable hepatocellular carcinoma
2009 · S. Wang, L. Keltner, et al. · Journal of Clinical Oncology · 9
Characterization of an antitumor immune response after light-activated drug therapy using talaporfin sodium in a spontaneously metastasizing mammary tumor model
2009 · E. Bromley, B. Owczarczak, et al. · Journal of Clinical Oncology · 5
Treatment of colorectal liver metastases using talaporfin sodium and intratumoral placement of LEDs
2005 · M. J. Winship, S.-S. Wang, et al. · Journal of Clinical Oncology · 4
Advanced Lung Cancer—Reaching a Survival Ceiling with Chemotherapy, the Nibs, and the Mabs
2011 · Riccardo Lencioni, James Chen, et al. · Journal of Cancer Therapy · 1
PDF
A phase IIa study of light-activated talaporfin sodium in patients with primary or recurrent glioblastoma multiforme
2009 · L. Keltner, J. C. Chen, et al. · Journal of Clinical Oncology · 1
Abstract 292: A dual CTLA4 and PD1 microbially derived inhibitor shows efficacy in anti-PD1 mAb unresponsive tumor models through a unique allosteric mechanism of action
2021 · Gabriel M. Gutierrez, Timothy W. Phares, et al. · Cancer Research
Unaltered IL-2 encapsulated in acoustically active lipid microspheres for systemic but targeted microdose delivery to tumor microenvironment.
2021 · Clayton Larsen, Llew Keltner, et al. · Journal of Clinical Oncology
Abstract No. 190: A phase I/II safety and efficacy study of intratumoral light-activated drug therapy using talaporfin sodium in patients with inoperable hepatocellular carcinoma
2011 · S. Wang, L. Keltner, et al. · Journal of Vascular and Interventional Radiology
Evaluation of a light-activated drug in a canine prostate model for focal therapy.
2010 · E. Bromley, J. C. Chen, et al. · Journal of Clinical Oncology
Light-activated Drug Therapy for Bph
2009 · Leonard S Marks, Malu Macairan, et al. · The Journal of Urology
Light-activated drug therapy in canine prostate
2008 · J. Christophersen, M. J. Winship, et al. · Journal of Clinical Oncology
A computerized disease register generator
1983 · Llew Keltner
Works count: 17
Citation count: 294
H-index: 5
I10-index: 4
Year
Topic
Type